NCT02687139View on ClinicalTrials.gov

Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

April 30, 2019

Study Completion Date

April 30, 2019

Conditions
Renal Cell CarcinomaKidney Cancer
Interventions
DRUG

18F-DCFPyL

PROCEDURE

PET/CT

Positron Emission Tomography - Computed Tomography (PET/CT)

Trial Locations (1)

21287

Johns Hopkins Hospital, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT02687139 - Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma | Biotech Hunter | Biotech Hunter